SOX2 and microphthalmia: A heterozygous inactivation of SOX2 causes syndromic microphthalmia-3 (MCOPS3), a genetic disease characterized by anophthalmia, microphthalmia mild hypopituitarism, and sometimes learning difficulties, convulsions, motor dysfunctions, and growth problems (4).